News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Schwartz Jeffrey Lawrence
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
05/25/2023 |
4
| Schwartz Jeffrey Lawrence (Director) has filed a Form 4 on SpringWorks Therapeutics, Inc.
Txns:
| Granted 4,648 shares
@ $0 Granted 13,774 options to buy
@ $32.27, valued at
$444.5k
|
|
05/05/2023 |
4
| Schwartz Jeffrey Lawrence (10% Owner) has filed a Form 4 on RAPID MICRO BIOSYSTEMS, INC.
Txns:
| Granted 25,000 options to buy
@ $0.8705, valued at
$21.8k
|
|
03/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/20/2022 |
4
| Schwartz Jeffrey Lawrence (Director) has filed a Form 4 on SpringWorks Therapeutics, Inc.
Txns:
| Granted 4,818 shares
@ $0 Granted 15,318 options to buy
@ $35.42, valued at
$542.6k
|
|
08/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/21/2021 |
4
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 4 on RAPID MICRO BIOSYSTEMS, INC.
Txns:
| Converted 6,999,998 shares
@ $0 Converted 1,334,562 shares
@ $0 Bought 100,000 shares
@ $20, valued at
$2M
Converted 35,000,001 options to buy
@ $0 Converted 6,672,819 options to buy
@ $0 |
|
07/16/2021 |
4
| Schwartz Jeffrey Lawrence (10% Owner) has filed a Form 4 on RAPID MICRO BIOSYSTEMS, INC.
Txns:
| Granted 25,000 options to buy
@ $20, valued at
$500k
|
|
07/14/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/27/2020 |
4
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 4 on Aptinyx Inc.
Txns:
| Bought 3,333,333 shares
@ $3, valued at
$10M
|
|
10/26/2020 |
4
| Schwartz Jeffrey Lawrence (CEO) has filed a Form 4 on BCLS Acquisition Corp.
Txns:
| Granted 487,500 shares
@ $10, valued at
$4.9M
|
|
10/21/2020 |
3
| Schwartz Jeffrey Lawrence (CEO) has filed a Form 3 on BCLS Acquisition Corp. |
07/28/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/23/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
05/22/2020 |
4
| Schwartz Jeffrey Lawrence (10% Owner) has filed a Form 4 on SpringWorks Therapeutics, Inc.
Txns:
| Granted 7,464 options to buy
@ $38.03, valued at
$283.9k
|
|
02/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/30/2020 |
3
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 3 on Arcutis Biotherapeutics, Inc. |
01/16/2020 |
3
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 3 on Aptinyx Inc. |
11/21/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/19/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
09/16/2019 |
4
| Schwartz Jeffrey Lawrence (10% Owner) has filed a Form 4 on SpringWorks Therapeutics, Inc.
Txns:
| Granted 29,983 options to buy
@ $18, valued at
$539.7k
Granted 40,000,000 convertible preferred
@ $0 Granted 6,931,142 convertible preferred
@ $0 |
|
09/12/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
05/31/2019 |
4
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 4 on Dicerna Pharmaceuticals Inc
Txns:
| Sold 1,600,000 shares
@ $12.5, valued at
$20M
|
|
07/26/2018 |
4
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 4 on Replimune Group, Inc.
Txns:
| Converted 2,338,968 shares
@ $0 Bought 500,000 shares
@ $15, valued at
$7.5M
Converted 235,146 convertible preferred
@ $0 |
|
07/19/2018 |
3
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 3 on Replimune Group, Inc. |
12/19/2017 |
4
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 4 on MARINUS PHARMACEUTICALS INC
Txns:
| Sold 719,665 shares
@ $8.0179, valued at
$5.8M
Sold 102,882 shares
@ $8.636, valued at
$888.5k
Sold 300,000 shares
@ $7.5048, valued at
$2.3M
Sold 94,771 shares
@ $7.6209, valued at
$722.2k
Sold 55,229 shares
@ $7.1055, valued at
$392.4k
|
|
12/19/2017 |
4
| Bain Capital Life Sciences Investors, LLC (10% Owner) has filed a Form 4 on Dicerna Pharmaceuticals Inc
Txns:
| Bought 285,000 shares
@ $7, valued at
$2M
Exercised 8,454,388 shares
@ $0 Granted 190,849 shares
@ $0 Exercised 250,000 options to buy
@ $3.19, valued at
$797.5k
|
|
04/13/2017 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|